126 related articles for article (PubMed ID: 28272216)
1. Nonorgan-specific autoantibodies in HIV-infected patients in the HAART era.
Iordache L; Bengoufa D; Taulera O; Rami A; Lascoux-Combe C; Day N; Parrinello M; Sellier PO; Molina JM; Mahr A
Medicine (Baltimore); 2017 Mar; 96(10):e6230. PubMed ID: 28272216
[TBL] [Abstract][Full Text] [Related]
2. [The clinical significance of serum autoantibodies and HLA-B(27) molecule testing in Uygur patients with human immunodeficiency virus infection].
Chen XM; Luo CN; Wu LJ; Shi YM; Wu X; Meng XY; Lei X; Liu Y; Reyimujiang Y; Gulimire K; Wang TY; Xia FF
Zhonghua Nei Ke Za Zhi; 2020 Mar; 59(3):195-199. PubMed ID: 32146745
[No Abstract] [Full Text] [Related]
3. Prevalence of 13 autoantibodies and of the 16/6 and related pathogenic idiotypes in 465 patients with systemic lupus erythematosus and their relationship with disease activity.
Villarreal GM; Drenkard C; Villa AR; Slor H; Shafrir S; Bakimer R; Shoenfeld Y; Alarcón-Segovia D
Lupus; 1997; 6(5):425-35. PubMed ID: 9229360
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies Among HIV-1 Infected Individuals and the Effect of Anti-Retroviral Therapy (ART) on It.
Steve RJ; Alex D; Yesudhason BL; Prakash JAJ; Mathews NS; Daniel D; Ramalingam VV; Demosthenes JP; Ghale BC; Anantharam R; Rebekah G; Rupali P; Varghese GM; Kannangai R
Curr HIV Res; 2021; 19(3):277-285. PubMed ID: 33596809
[TBL] [Abstract][Full Text] [Related]
5. Reduction of viral load and immune complex load on CD4+ lymphocytes as a consequence of highly active antiretroviral treatment (HAART) in HIV-infected hemophilia patients.
Daniel V; Süsal C; Melk A; Weimer R; Kröpelin M; Zimmermann R; Huth-Kühne A; Uhle C; Opelz G
Immunol Lett; 1999 Aug; 69(2):283-9. PubMed ID: 10482364
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and clinical significance of nonorgan specific antibodies in patients with autoimmune thyroiditis as predictor markers for rheumatic diseases.
Elnady BM; Kamal NM; Shaker RHM; Soliman AF; Hasan WA; Alghamdi HA; Algethami MM; Jajah MB
Medicine (Baltimore); 2016 Sep; 95(38):e4336. PubMed ID: 27661011
[TBL] [Abstract][Full Text] [Related]
7. Anticardiolipin antibodies in HIV infection are independently associated with antibodies to the membrane proximal external region of gp41 and with cell-associated HIV DNA and immune activation.
Martinez V; Diemert MC; Braibant M; Potard V; Charuel JL; Barin F; Costagliola D; Caumes E; Clauvel JP; Autran B; Musset L;
Clin Infect Dis; 2009 Jan; 48(1):123-32. PubMed ID: 19035778
[TBL] [Abstract][Full Text] [Related]
8. Oral manifestations of an HIV positive cohort in the era of highly active anti-retroviral therapy (HAART) in South London.
Eyeson JD; Tenant-Flowers M; Cooper DJ; Johnson NW; Warnakulasuriya KA
J Oral Pathol Med; 2002 Mar; 31(3):169-74. PubMed ID: 11903824
[TBL] [Abstract][Full Text] [Related]
9. Immunological and virological responses to highly active antiretroviral therapy in a non-clinical trial setting in a developing Caribbean country.
Kilaru KR; Kumar A; Sippy N; Carter AO; Roach TC
HIV Med; 2006 Mar; 7(2):99-104. PubMed ID: 16420254
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune diseases-related arthritis in HIV-infected patients in the era of highly active antiretroviral therapy.
Yang JJ; Tsai MS; Sun HY; Hsieh SM; Chen MY; Sheng WH; Chang SC
J Microbiol Immunol Infect; 2015 Apr; 48(2):130-6. PubMed ID: 24064287
[TBL] [Abstract][Full Text] [Related]
11. Can highly active antiretroviral therapy be interrupted in patients with sustained moderate HIV RNA and > 400 CD4+ cells/microl? Impact on immunovirological parameters.
Pellegrin I; Thiébaut R; Blanco P; Viallard JF; Schrive MH; Merel P; Chêne G; Fleury H; Moreau JF; Pellegrin JL
J Med Virol; 2005 Oct; 77(2):164-72. PubMed ID: 16121362
[TBL] [Abstract][Full Text] [Related]
12. Micronutrient levels and HIV disease status in HIV-infected patients on highly active antiretroviral therapy in the Nutrition for Healthy Living cohort.
Jones CY; Tang AM; Forrester JE; Huang J; Hendricks KM; Knox TA; Spiegelman D; Semba RD; Woods MN
J Acquir Immune Defic Syndr; 2006 Dec; 43(4):475-82. PubMed ID: 17019373
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune diabetes in HIV-infected patients on highly active antiretroviral therapy.
Takarabe D; Rokukawa Y; Takahashi Y; Goto A; Takaichi M; Okamoto M; Tsujimoto T; Noto H; Kishimoto M; Kaburagi Y; Yasuda K; Yamamoto-Honda R; Tsukada K; Honda M; Teruya K; Kajio H; Kikuchi Y; Oka S; Noda M
J Clin Endocrinol Metab; 2010 Aug; 95(8):4056-60. PubMed ID: 20484483
[TBL] [Abstract][Full Text] [Related]
14. CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study.
McDermott AY; Terrin N; Wanke C; Skinner S; Tchetgen E; Shevitz AH
Clin Infect Dis; 2005 Dec; 41(11):1662-70. PubMed ID: 16267741
[TBL] [Abstract][Full Text] [Related]
15. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
[TBL] [Abstract][Full Text] [Related]
16. Immunologic and virological response to ART among HIV infected individuals at a tertiary hospital in Ghana.
Obiri-Yeboah D; Pappoe F; Baidoo I; Arthur F; Hayfron-Benjamin A; Essien-Baidoo S; Kwakye-Nuako G; Ayisi Addo S
BMC Infect Dis; 2018 May; 18(1):230. PubMed ID: 29783953
[TBL] [Abstract][Full Text] [Related]
17. Seven antiphospholipid antibodies in HIV-positive patients: correlation with clinical course and laboratory findings.
Sedlácek D; Ulcová-Gallová Z; Milichovská L; Nováková P; Rokyta Z
Am J Reprod Immunol; 2003 Dec; 50(6):439-43. PubMed ID: 14750550
[TBL] [Abstract][Full Text] [Related]
18. Neurological complications of HIV infection in pre-HAART and HAART era: a retrospective study.
Matinella A; Lanzafame M; Bonometti MA; Gajofatto A; Concia E; Vento S; Monaco S; Ferrari S
J Neurol; 2015 May; 262(5):1317-27. PubMed ID: 25877836
[TBL] [Abstract][Full Text] [Related]
19. Sequential occurrence of thyroid autoantibodies and Graves' disease after immune restoration in severely immunocompromised human immunodeficiency virus-1-infected patients.
Jubault V; Penfornis A; Schillo F; Hoen B; Izembart M; Timsit J; Kazatchkine MD; Gilquin J; Viard JP
J Clin Endocrinol Metab; 2000 Nov; 85(11):4254-7. PubMed ID: 11095463
[TBL] [Abstract][Full Text] [Related]
20. Residual viraemia in HIV-1-infected patients with plasma viral load Ostrowski SR; Katzenstein TL; Pedersen BK; Gerstoft J; Ullum H
Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
